PMID: 11312691Apr 21, 2001Paper

Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate

Bioconjugate Chemistry
X Guo, F C Szoka

Abstract

We describe the synthesis and characterization of a pH-sensitive poly(ethylene glycol)-diortho ester-distearoyl glycerol conjugate (POD). POD was prepared by a one-step synthesis, and its acid sensitivity characterized by TLC. The conjugate was found to be stable at neutral pH for greater than 3 h but degraded completely within 1 h at pH 5. Liposomes composed of 10% of POD and 90% of a fusogenic lipid, dioleoyl phosphatidylethanolamine (DOPE) were readily prepared and remained stable for up to 12 h in neutral buffer as shown by photon correlation spectrometry and a liposome contents leakage assay. However, when POD/DOPE liposomes were incubated in acidic pH as mild as 5.5, they aggregated and released most of their contents within 30 min. The kinetics of content release from POD/DOPE liposomes consisted of two phases, a lag phase, and a burst phase. The lag phase is inversely correlated with pH and the logarithm of the length of lag phase showed a linear relationship with the buffer pH. When the POD/DOPE liposomes were incubated in 75% of fetal bovine serum at 37 degrees C, they remained as stable as traditional PEG-grafted liposomes for 12 h but released 84% of the encapsulated ANTS in the following 4 h. Upon intravenous admin...Continue Reading

References

Jan 10, 1992·Biochimica Et Biophysica Acta·A Gabizon, D Papahadjopoulos
Aug 10, 1992·Biochimica Et Biophysica Acta·V C Anderson, D H Thompson
Jan 1, 1986·Annual Review of Biochemistry·I MellmanA Helenius
Nov 1, 1984·Journal of Pharmaceutical Sciences·T H NguyenT Higuchi
Apr 20, 1994·Biochimica Et Biophysica Acta·D V DevineP R Cullis
Aug 6, 1999·Gene Therapy·J J WheelerP R Cullis

❮ Previous
Next ❯

Citations

Jan 26, 2007·Pharmaceutical Research·Weijun Li, Francis C Szoka
Mar 28, 2007·Pharmaceutical Research·Verena Russ, Ernst Wagner
Jun 7, 2007·Pharmaceutical Research·Birgit RombergGert Storm
May 1, 2012·Pharmaceutical Research·Juliane NguyenFrancis Szoka
Apr 7, 2004·Advanced Drug Delivery Reviews·Sérgio SimõesMaria C Pedroso de Lima
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Junhwa ShinDavid H Thompson
Jul 2, 2003·Biophysical Chemistry·Nill BergstrandKatarina Edwards
Jan 31, 2013·Biochemistry·Anna MoshnikovaYana K Reshetnyak
Jan 5, 2006·Journal of the American Chemical Society·Zhaohua HuangFrancis C Szoka
Dec 9, 2008·Journal of the American Chemical Society·Andrew P GoodwinHongjie Dai
Aug 3, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Corbin ClawsonLiangfang Zhang
Apr 25, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yuan ZhangLeaf Huang
Oct 24, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jon A Wolff, David B Rozema
Oct 22, 2005·Chemical Society Reviews·Kostas Kostarelos, Andrew D Miller
Oct 3, 2008·Chemical Communications : Chem Comm·Barbora BrazdovaXin Guo
Apr 6, 2007·The AAPS Journal·Xiang GaoDexi Liu
Jul 7, 2007·The AAPS Journal·Vladimir P Torchilin
Mar 15, 2012·The AAPS Journal·Rupa R Sawant, Vladimir P Torchilin
Oct 6, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hiroto HatakeyamaHideyoshi Harashima
Dec 7, 2013·Therapeutic Delivery·Xi HeChen Jiang
Jul 28, 2012·Therapeutic Delivery·Yaling LiuVladimir R Muzykantov
Sep 13, 2013·Therapeutic Delivery·Diego Dos Santos FerreiraMônica Cristina Oliveira
Apr 29, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jean-Michel RabanelXavier Banquy
Jun 7, 2011·Annual Review of Biomedical Engineering·Leaf Huang, Yang Liu
Jul 8, 2014·Therapeutic Delivery·Andrew D Miller
Oct 1, 2005·Journal of Liposome Research·Martin BartschJan A A M Kamps
May 16, 2009·Expert Opinion on Therapeutic Patents·Xiao-Jie JuLiang-Yin Chu
Nov 8, 2013·Expert Review of Medical Devices·Andrew D Miller
Feb 16, 2012·Journal of Drug Targeting·Daiki OmataYukihiko Aramaki
Jun 26, 2013·Expert Opinion on Drug Delivery·Erik Oude BlenkeRaymond M Schiffelers
Feb 25, 2009·Expert Opinion on Drug Delivery·Takeshi Kasuya, Shun'ichi Kuroda
Jul 23, 2004·Expert Opinion on Biological Therapy·M Ravi KumarShyam S Mohapatra
Mar 25, 2010·Expert Opinion on Drug Delivery·Mary Caldorera-MooreKrishnendu Roy
Apr 12, 2002·Journal of Pharmaceutical Sciences·Aravind Asokan, Moo J Cho
Sep 15, 2012·Advanced Drug Delivery Reviews·Ala Daka, Dan Peer
Apr 7, 2012·European Journal of Medicinal Chemistry·Haigang ChenXin Guo
Oct 22, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tessa LuhmannLorenz Meinel
Jul 30, 2011·International Journal of Pharmaceutics·Tao WangVladimir P Torchilin
May 31, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Taichi IshitsukaHideyoshi Harashima
Aug 31, 2010·International Journal of Pharmaceutics·Jin-Ki KimSeongbong Jo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.